




Objective: The interaction between solifenacin succinate (SFS) and herring sperm DNA (Hs-DNA) was investigated by using UV–vis and 
fluorescence spectra at pH 7.4.  
Methods: The UV-vis and fluorimetric titrations were performed by keeping the concentration of SFS constant and varying the concentration of Hs-
DNA in a buffer solution of pH 7.4. The absorption spectra shows an increase in absorbance at an absorption band of SFS with increasing 
concentration of Hs-DNA. A quenching of intrinsic fluorescence of SFS was observed with the increasing of Hs-DNA concentration. 
Results: The fluorescence lifetime results, the varieties of the fluorophore absorption spectra and the decrease of the binding constant with the 
increasing temperature all indicate that the fluorescence quenching is static. The ratio and constant of the binding Hs-DNA to SFS are 1 and 6.76 x 10
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respectively. The values of ΔH, ΔS and ΔG obtained for SFS-Hs-DNA were - 9.93 kJ/mol, 0.17 kJ/(mol K) and - 44.78 kJ/mol respectively at 298 K. 
Conclusions: The absorption spectra and fluorescence quenching spectra of SFS in presence of Hs-DNA strongly supports the interaction of SFS 
with Hs-DNA. SFS binds to Hs-DNA with a binding constant of 6.76 x 105
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 at 298 K. In addition, thermodynamic data for the SFS binding to Hs-DNA 
showed that the binding of SFS to Hs-DNA is not only exothermic but entropy-driven. 
 
INTRODUCTION 
The biological activity of many small molecular drugs, has been 
known to play important roles in medicinal chemistry due to their 
interaction with DNA. The study of an interaction mechanism 
between drug and DNA has promoted the developing of new drugs. 
Interaction between drugs and DNA is an active research area [1,2].  
Solifenacin succinate is a competitive muscarinic acetylcholine 
receptor antagonist. The binding of acetylcholine to these receptors, 
particularly the M3
3
 receptor subtype, plays a critical role in the 
contraction of the smooth muscle. By preventing the binding of 
acetylcholine to these receptors, solifenacin succinate reduces the 
smooth muscle tone in the bladder, allowing the bladder to retain 
larger volumes of urine and reducing the number of micturition, 
urgency and incontinence episodes [ ,4]. A literature survey reveals 
one HPLC [5], one mass spectrometry [6] and one 
spectrophotometeric method [7] for the assay of SFS. But so far, 
there has not any report about the interactive study of SFS with DNA 
based on spectroscopic behaviour.  
A variety of analytical techniques have been employed to investigate 
the interaction of small molecular drug with DNA. 
Spectrofluorimetry is one of the excellent methods for its 
convenience and high sensitivity. Thus, in this work, efforts are 
being made to study the interaction of SFS with Hs-DNA at 
physiological conditions (pH 7.4) by using UV-vis and fluorescence 
spectra. The UV–vis spectra was recorded on a double beam Ellico 
UV-visible spectrophotometer (INDIA) in matched quartz cell of 1-
cm path length. The fluorescence measurements were carried out on 
a HITACHI F-4500 spectrofluorimeter equipped with a 150W Xenon 
lamp and 1-cm quartz cell. The titrations were performed by 
keeping the concentration of SFS constant and varying the 
concentration of Hs-DNA. The pH measurements were made with 
Scott Gerate pH meter CG 804. An electronic thermostat water-bath 
was used for controlling the temperature. 
Hs-DNA with a purity of ˃ 98 % was purchased from Sigma Aldrich 
(India). SFS with a purity of ˃ 99% was kindly supplied by Hetero Drugs 
limited, Hyderabad, India. They were used without further purification. 
The solutions were stored at 4˚C before being used. A buffer solution of 
pH 7.4 was prepared by following the standard methods. Analytical 
grade reagents and double distilled water were used in all experiments.  
Interaction between SFS and Hs-DNA has been characterized 
classically by UV-vis absorption spectra. The effect of progressively 
increasing concentration of Hs-DNA on the absorption spectrum of 
SFS is shown in Fig. 1. The absorption spectra of SFS present one 
peak at 256 nm in the range of 200 - 400 nm. The absorption spectra 
show an increase of peak intensity about 26.4 % and a small red 
shift about 10 nm at an absorption band of SFS with increasing 
concentration of Hs-DNA. The hypochromicity and bathochromicity 
of an absorption band are due to the effective interaction between 
SFS with Hs-DNA. The varieties of absorption spectra are due to the 
effective interaction between SFS with Hs-DNA. A strong fluorescence 
emission spectrum of SFS at 460 nm was observed in the range of 350–
550 nm after excitation at 256 nm. The fluorescence emission spectra of 
SFS increased with increasing concentration of Hs-DNA (Fig. 2). A 
quenching of intrinsic fluorescence of SFS was observed with the 
increasing concentration of Hs-DNA, but not altering the emission 
maximum and shape of the peak. These results show that there are the 
binding between SFS and Hs-DNA. The fluorescence intensity tends to be 
constant at a high concentration of Hs-DNA, which shows the binding of 
SFS to Hs-DNA reached saturation.  
 













Fig. 1: Absorption spectral changes of SFS (1x10-4 mol/L) with 
increasing concentration of Hs-DNA (from down to up 2 – 12 μ 
mol/L) in the buffer of pH 7.4. 
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Fig. 2: Fluorescence emission spectra of SFS (1.5 x 10-5 mol/L) 
with increasing concentration of Hs-DNA (from down to up 5 - 
35 μ mol/L) in pH 7.4 buffer. 
 
The varieties of the fluorescence excitation spectra of SFS caused by 
gradually increasing the concentration of Hs-DNA were shown in 
Fig. 2. Fluorescence relative intensities of SFS has a gradual increase 
with the increasing concentration of Hs-DNA, which indicates that 
binding formed by SFS and Hs-DNA. This phenomenon also proves 
that the fluorescence quenching is static. 
The binding constants of SFS with Hs-DNA were calculated from the 
data of fluorescence spectra. The binding constant K and the binding 
number n are calculated by the following equation (1) [8]:  
M + nQ ↔ MQn                                           ....(1) 
Where Q is the quencher known as Hs-DNA, M the SFS, and MQn is 
the binding of them. 
                                                   ....(2) 
Where K is the intrinsic binding constant, and n is the binding 
number of Hs-DNA to SFS. [M] is the concentration of free SFS, and 
[MQn] is the concentration of binding. If [M]0 is the total 
concentration of SFS.  
[M]0 = [M] + [MQn]                                   ....(3) 
When [Q] [M], the concentration of free quencher is replaced by the 
initial concentration. 
         ….. (4) 
In static quenching, according to above equation, the following 
formula can be obtained: 
                     …. (5) 
Stern-Volmer plot of F0/F to [Q] is shown in Fig.3. By linear analysis 
from the data, a binding constant K is calculated out as 6.76 x 105











298 K. Binding parameters of SFS-Hs-DNA binding at different 
temperatures were shown in Table 1. 
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Fig. 4: Van’t Hoff plot of ln K vs 1/T for SFS-Hs-DNA system 
 
Fluorescence measurements of SFS-Hs-DNA binding were 
performed at different temperatures. Thermodynamic parameters 
were estimated by the analysis of ln K vs 1/T plot (Van’t Hoff plot) 
obtained by the experimental data at different temperatures (Fig. 4). 
The gradient of this straight line of ln K vs 1/T is equal to ΔH/R 
which indicates the value of ΔH, ΔG and ΔS can be calculated from 
the following relationships: 
ΔG = - RT ln K                             ....(6) 
ΔG = - ΔH - TΔS                          ....(7) 
The Van’t Hoff plot for the binding of SFS to Hs-DNA is depicted in 
Fig. 4. The values of thermodynamic parameters are shown in Table 
1. It can be seen that the SFS binding to Hs-DNA is characterized by 
negative enthalpy and positive entropy changes. It is known that the 
occurrence of reaction requires a negative ΔG, and since enthalpy is 
negative, the interaction of SFS with Hs-DNA should be entropy-
driven. In addition, positive enthalpy of the reaction between SFS 
and Hs-DNA hints the increase temperature at an exothermic 
process, therefore, the increase of temperature is in favor of the 
reverse direction of the reaction (Eq. 2), resulting in smaller values 
of binding constant K (or quenching constant) with increasing 
temperature. Decreasing of the binding constant with increasing 
temperature also suggests that the fluorescence quenching is static. 
At the same time, from the viewpoint of molecular stability, the 
reduced stability of bindings with increasing temperature can also 
decrease the K value. 
 
Table 1: Thermodynamic parameters for the SFS-Hs-DNA complexation obtained from fluorescence measurements in buffer solution of 
pH 7.4. 
Temperature T in K Binding Constant K (x 105 ΔG (kJ/mol) ) ΔH (kJ/mol) ΔS (kJ/(molK)) 
288 1.44 - 43.57 - 9.93 0.17 
298 6.76 - 44.78 - 9.93 0.17 
308 4.03 - 45.90 - 9.93 0.17 
318 2.21 - 48.83 - 9.93 0.17 
Gowda et al. 




The binding of SFS to Hs-DNA results in hypochromism and 
bathochromism in absorption spectra and fluorescence quenching in 
fluorescence emission spectra. These spectra features strongly 
support the interactions of SFS with Hs-DNA. SFS binds to Hs-DNA 
with a binding constant of 6.76 x 105
1. Li SY, Ren YZ, Zhao FL. Chinese Chemical Letters 
2006;17(8):1065-68. 
 at 298 K. In addition, 
thermodynamic data for the SFS binding to Hs-DNA were also 
calculated and derived from experimental measurements, with the 
results of ΔH = - 9.93 kJ/mol, ΔG = - 44.78 kJ/mol and ΔS = 0.17 
kJ/(mol K) at 298 K. These results show that the binding of SFS to 
Hs-DNA is not only exothermic but entropy-driven. 
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